POSC106 Budget Impact Analysis of Including Sacubitril/Valsartan in the National Formulary for the Treatment of Heart Failure with Reduced Ejection Fraction (HFREF) in Thailand
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.511
https://www.valueinhealthjournal.com/article/S1098-3015(21)02306-8/fulltext
Title :
POSC106 Budget Impact Analysis of Including Sacubitril/Valsartan in the National Formulary for the Treatment of Heart Failure with Reduced Ejection Fraction (HFREF) in Thailand
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02306-8&doi=10.1016/j.jval.2021.11.511
First page :
Section Title :
Open access? :
No
Section Order :
10045